OncoMed Pharmaceuticals Inc: accounts_payable
| Value | {"amount": 5706000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2013-12-31) |
| Status | current |
| Entity | OncoMed Pharmaceuticals Inc |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:24:56.830834+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0621d8ce-e412-4edc-9077-775eae84e7a4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-14-104564 · Open the official SEC filing →Retrieved: 2026-08-19T12:24:56.830834+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001302573/accounts-payable/2013-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0621d8ce-e412-4edc-9077-775eae84e7a4
History
- no predecessors — first report